MIMIC-\RNum{4}-Ext-22MCTS:一个2200万事件的时间临床时间序列数据集,具有风险预测的相对时间
ArXiv
|July 30, 2025
概括
这项研究引入了一个新的数据集,包含从出院摘要中提取的超过2200万个临床时间序列事件. 这一数据集增强了机器学习模型,以改善医疗保健应用,包括医疗问题答案和临床试验匹配.
科学领域:
- 医疗信息学 医疗信息学
- 自然语言处理自然语言处理.
- 机器学习 机器学习
背景情况:
- 高质量的临床时间序列数据对于准确的基于机器学习的医疗风险预测至关重要.
- 像MIMIC-IV-Note这样的现有数据集包含非结构化的出院摘要,由于长度和缺乏临床事件的明确时间,这就带来了挑战.
研究的目的:
- 从非结构化的离院摘要中创建一个新的,大规模的临床时间序列事件数据集 (MIMIC-4-Ext-22MCTS).
- 开发一个强大的框架,从漫长的医学文本中提取临床事件及其时间信息.
- 通过使用这个新数据集,提高机器学习模型在医疗保健应用中的性能.
主要方法:
- 开发了一个框架,通过将它们分成更小的块来处理冗长的排放摘要.
- 利用上下文BM25和语义搜索来识别包含临床事件的相关文本块.
- 采用Llama-3.1-8B模型的快速工程来识别和推断临床事件的时间.
主要成果:
- 创建了MIMIC-4-Ext-22MCTS数据集,包括22,588,586个临床时间序列事件.
- 对此数据集的微调标准模型导致了医疗保健任务的显著性能改善.
- 伯特模型在回答医疗问题方面提高了10%的准确性,在临床试验匹配方面增加了3%.
结论:
- MIMIC-4-Ext-22MCTS数据集提供了信息丰富和透明的临床时间序列数据.
- 这一数据集有效地提高了关键医疗保健应用的机器学习模型的性能.
- 拟议的框架提供了一个可扩展的解决方案,用于从非结构化的医疗记录中提取时间临床事件数据.
相关概念视频
Prediction Intervals
2.3K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
2.3K
Relative Risk
348
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
348
End Point Prediction: Gran Plot
590
A Gran plot is used to predict the equivalence volume or endpoint of a potentiometric or acid-base titration without reaching the endpoint. Typically, titration data is collected as a function of the titrant's volume up to a point less than the equivalence volume and then transformed into a linear format. The straight line is extended to the x-axis, indicating the necessary titrant volume to achieve the equivalence point.
For potentiometric titration, the Gran plot is created by plotting...
For potentiometric titration, the Gran plot is created by plotting...
590
Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K
Kaplan-Meier Approach
270
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
270
Hazard Ratio
251
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
251


